https://www.selleckchem.com/pr....oducts/blebbistatin.
Six OS-, ten PFS-, and five DFS-related ERGs were obtained. By constructing the prognostic risk score model, we found that the OS, PFS, and DFS of the high-risk group were notably poorer. Last, we found that AQP5 appeared in all three gene signatures, and through pan-cancer analysis, it was also found to play an important role in immunity in lower grade glioma (LGG), which may contribute to the poor prognosis of LGG patients. We constructed ERG signatures to predict the prognosis of EC patients using bioinformatics methods. Our fin
Curtir
Comentario
Compartilhar
